TSPYL2 Is Important for G1 Checkpoint Maintenance upon DNA Damage by Tao, Kin Pong et al.
TSPYL2 Is Important for G1 Checkpoint Maintenance
upon DNA Damage
Kin Pong Tao
1, Sze Wan Fong
1, Zhihong Lu
1, Yick Pang Ching
2, Kin Wang Chan
1, Siu Yuen Chan
1*
1Department of Paediatrics and Adolescent Medicine, Center of Reproduction, Development and Growth, Li Ka Shing Faculty of Medicine, The University of Hong Kong,
Hong Kong, China, 2Department of Anatomy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
Abstract
Nucleosome assembly proteins play important roles in chromatin remodeling, which determines gene expression, cell
proliferation and terminal differentiation. Testis specific protein, Y-encoded-like 2 (TSPYL2) is a nucleosome assembly
protein expressed in neuronal precursors and mature neurons. Previous studies have shown that TSPYL2 binds cyclin B and
inhibits cell proliferation in cultured cells suggesting a role in cell cycle regulation. To investigate the physiological
significance of TSPYL2 in the control of cell cycle, we generated mice with targeted disruption of Tspyl2. These mutant mice
appear grossly normal, have normal life span and do not exhibit increased tumor incidence. To define the role of TSPYL2 in
DNA repair, checkpoint arrest and apoptosis, primary embryonic fibroblasts and thymocytes from Tspyl2 deficient mice were
isolated and examined under unperturbed and stressed conditions. We show that mutant fibroblasts are impaired in G1
arrest under the situation of DNA damage induced by gamma irradiation. This is mainly attributed to the defective
activation of p21 transcription despite proper p53 protein accumulation, suggesting that TSPYL2 is additionally required for
p21 induction. TSPYL2 serves a biological role in maintaining the G1 checkpoint under stress condition.
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Introduction
Nucleosome assembly proteins (NAPs) play important roles in
the control of cell proliferation. They are divided into NAP, SET
and TSPY families according to the amino acid conservation of
the NAP domain. NAPs are involved in cell cycle control through
regulating the transcription of cell cycle genes and through
interaction with cyclins [1,2]. Knockout of NAP1, the prototypic
NAP family member, is embryonic lethal in Drosophila [3]. In yeast,
NAP1 binds the mitotic cyclin Clb2 (homologue of cyclin B) and
the protein kinase Gin4, thereby inducing cell cycle events [4,5].
Testis-specific protein, Y-encoded (TSPY) also interacts with
cyclin B and enhances cyclin B-CDK1 phosphorylation [6]. As the
first TSPY family member being identified, TSPY accelerates cell
proliferation, and is related to testicular and prostate cancers
[7,8,9].
TSPY-like 2 (TSPYL2, also named as CDA1, CINAP,
DENTT, NP79, Se20-4 and TSPX) is involved in cell cycle
control, but in an opposite manner to the effect of TSPY. Whereas
TSPY increases cyclin B-CDK1 activity, TSPYL2 inhibits its
activity. The NAP domain performs the same function of binding
cyclin B, but the acidic C-terminal tail in TSPYL2, and in another
NAP member SET, is responsible for the inhibitory effect on
cyclin B-CDK activity [6]. In agreement to this finding, SET
overexpression retards cell cycle transition at G2/M [10]. By
contrast the effect of TSPYL2 on cell cycle profile is not obvious
although it can also arrest cell growth and inhibit DNA synthesis
[11]. TSPYL2 may play a role in arresting cell growth upon DNA
damage, as it can be induced by camptothecin, a topoisomerase
inhibitor that induces DNA strand breaks [12]. TSPYL2 is also
upregulated by TGFb1, a cytokine that blocks the advancement
from G1 to S phase, in responsive non-small-cell lung carcinoma
cell lines [13]. Together with the fact that TSPYL2 can repress
cyclin B-CDK1 activities, the major regulator complex during G2
to M phase progression, the data suggest that TSPYL2 can inhibit
both G1/S and G2/M phases of the cell cycle. In agreement with
the notion that TSPYL2 is a negative cell cycle regulator, TSPYL2
is silenced in glioma tissues, malignant lung tissues and certain
lung tumor cell lines [14,15]. Overexpression of TSPYL2 in
human lung and breast cancer cell lines results in reduced growth
potential [15]. Nevertheless, direct evidence of a physiological
function of TSPYL2 in cell cycle control is lacking. Loss-of-
function analysis is a powerful approach to address this question.
Loss-of-function of NAPs has been associated with human
diseases. A frameshift mutation which results in truncation of the
NAP domain in TSPYL1 is found in sudden infant death with
dysgenesis of the testis syndrome [16]. Mouse embryos with
deletion of the Nap1l2 gene exhibit neural tube defects closely
resembling spina bifida and anencephaly, and NAP1L2 may be
related to X-linked neural tube defects in humans [17,18]. It is
essential to validate the in vitro findings of TSPYL2 on cell cycle
control and tumor suppression in vivo, as exemplified by elegant
studies on various mouse mutants of p53 which demonstrate that
in vivo findings can contradict the results in biochemical assays and
cell line studies [19]. Here we report the generation and analysis of
TSPYL2 deficient mice. The mutant mice generated are viable,
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radiation (IR) was employed for studying the DNA damage
response without the complications of stalled transcription from
ultraviolet light and topoisomerase inhibitors [20]. Primary
cultures of mouse embryonic fibroblasts (MEFs) and thymocytes
were isolated as they serve as well-established models for studying
cell cycle control and apoptosis, respectively. We find that MEFs
lacking functional Tspyl2 proliferate normally, but are impaired in
G1 arrest following DNA damage. Despite proper stabilization of
p53, induction of p21 transcription is specifically impaired. Our
data demonstrate that loss of TSPYL2 function is not deleterious
to the development of mice, and reveal the importance of TSPYL2
in the maintenance of G1 checkpoint under stress condition.
Materials and Methods
Ethics statement
Mouse experiments were approved and performed according to
the instructions of Committee on the Use of Live Animals in
Teaching and Research at the University of Hong Kong (approval
ID: CULATR 1643-08).
Gene targeting, genotyping and mouse lines
In view of the potential importance of TSPYL2 in cell proliferation
and brain development, a conditional knockout construct was
designed. The neomycin resistance (neo) cassette with the phospho-
glycerate kinase 1 promoter and polyA was franked by frt sites and
inserted into intron 5 of Tspyl2. This allowed the removal of the neo
cassette by flip recombinase so that it would not interfere with the
transcription of Tspyl2. Exons 2 to 5, together with the neo cassette
oriented in opposite direction to Tspyl2 transcription, was flanked by
loxP sites. Exons 2 to 5, which encoded the NAP domain, could be
conditionally deleted by expression of Cre recombinase. The targeting
vector contained 4.0 kb of 59 and 1.9 kb of 39 homology arms.
Embryonic stem (ES) cells were derived in house from 129Sv/Ev
embryos by the Transgenic Core Facility at HKU, which also
provided the service for electroporations and blastocyst injections.
Homologous recombination in the G418 resistant ES clones was
detected by Southern blot analysis using standard procedures. Probes
for Southern blotting were derived from PCR, cloned and sequence
verified. Chimeric mice were generated by injecting the targeted ES
clones into C57BL/6 blastocysts, and mated to 129Sv/Ev mice.
Germline transmission of the mutant Tspyl2 allele (Tspyl2
m)w a s
validated by PCR genotyping using primers binding Tspyl2 exon 5
(F5: 59 CTACTATATGAGACGAGG) and neo (neo-R: 59 TGAA-
GAACGAGATCAGCAGC). The wildtype Tspyl2 allele was detected
using primers for exon 5 (F5) and exon 6 (R6: 59 TGGTCAG-
GATCTTCACTGTC). The mouse line was called Tspyl2
m and
maintained in pure 129Sv/Ev background.
To remove exons 2 to 5 in Tspyl2
m allele for the generation of
Tspyl2 deleted mouse line, Tspyl2
m/Y mice were mated to female
transgenic mice that expressed Cre recombinase under the
promoter for zona pellucida glycoprotein 3 [21]. The transgenic females
originated from injected FVB/N oocytes and were subsequently
bred into Swiss outbred background. Germline Cre-mediated
excision of exons 2 to 5 was confirmed by PCR using primers for
intron 1 (C1: 59 CTTAGCATCTAGACCTACAGC) and exon 6
(R6). First generation offspring with the deleted allele (Tspyl2
2) but
not the Cre transgene as determined by PCR were used to establish
the Tspyl2
2 line by brother to sister mating.
Northern Blot
Ten micrograms of RNA were resolved in 1% formaldehyde
agarose gel. The blot was hybridized in Church buffer at 65uC
with [aP
32]-dCTP labeled probes covering nucleotide 545 - 1033
of Tspyl2 mRNA (NM_029836.3). The blot was washed twice with
2X SSC/0.1% SDS at 65uC for 10 minutes each, and then three
times with 1X SSC/0.1% SDS at 65uC for 15 minutes each.
Brain histology and immunohistochemistry
Mice were intraperitoneally injected with 95 mg/g 5-bromo-2-
deoxyuridine (BrdU) in saline for six consecutive days. Brains were
collected after transcardial perfusion with 4% paraformaldehyde
and fixed overnight. Brains were cryoprotected in 30% sucrose,
and serial coronal sections of 40 mm were cut using a freezing
microtome. After mounting, sections were incubated in citrate
buffer (pH 6.0) at 85uC for 25 minutes. After 3 washes in PBS,
sections were incubated with 37uC prewarmed 2M hydrochloric
acid for 10 minutes, followed by 0.1 M borate buffer (pH 8.5) for
15 minutes for partial denaturation of DNA before commencing to
conventional immnohistochemistry protocol. Staining was per-
formed with anti-BrdU (Developmental Studies Hybridoma Bank)
and Alexa FluorH 488 goat anti-mouse IgG antibody (Invitrogen).
The epiflorescence was observed using Axioplan-2 Carl Zeiss
system, and the number of BrdU positive cells in the whole dentate
gyrus was counted on one-in-six sections, omitting the outermost
focal plane. The total number of BrdU positive cells being counted
was multiplied by six to obtain the number for the entire dentate
gyrus. For the lateral ventricle, the number of BrdU positive cells
in corresponding region (Bregma level of 20.8 mm) was counted
in one section, and the average was taken from three mice for each
genotype.
Cell harvest, culture and treatments
MEFs were isolated from 12.5–14.5 day post-coitum embryos
from heterozygous females mated with mutant males, and
routinely passaged using the standard 3T3 protocol. MEFs were
cultured in Dulbecco’s modified Eagle’s medium (Invitrogen)
supplied with 10% fetal bovine serum (HyClone) at 37uC and 5%
CO2. Single cell suspension of thymocytes was obtained by passing
the dissected thymus from 2-months old mice through a 40 mm
cell strainer (Falcon) followed by red blood cell lysis. Thymocytes
were cultured overnight in Roswell Park Memorial Institute
medium (Invitrogen) supplemented with 10% fetal bovine serum.
For synchronization of MEFs in G1 or G2 phase, cells were
incubated with 5 mg/ml aphidicolin (Biomol) or 80 ng/ml
nocodazole (Sigma-Aldrich) for 12 hours. The IR experiments
were performed by Gammacell 3000 Elan irradiator (MDS
Nordion).
Flow cytometry
For cell cycle analysis, culture cells were collected by
trypsinization, and fixed overnight at 220uC in 70% ethanol.
Right before Flow analysis, cells were suspended in propidium
iodide (PI) staining solution (Invitrogen) containing RNase for 15
minutes at room temperature. Cells were applied to EPICS Elite
Flow Cytometer (Beckman Coulter) or LSRII (BD Biosciences).
Cell cycle profiles were analyzed by ModFitH (Verity Software
House). For analysis of apoptotic response, freshly isolated
thymocytes from mice untreated or irradiated at 4 Gy were
washed and stained with FITC tagged anti-CD4 and PE-Cy5
tagged anti-CD8 antibodies (BD Biosciences) for 1 hour, followed
by Flow analysis. For Annexin V-PI (AVPI) experiment,
thymocytes were collected from untreated mice, cultured over-
night and subjected to 10 Gy IR. Cultures were collected at
various time points for staining with BD Pharmingen
TM Annexin
V: FITC Apoptosis Detection Kit II according to manufacturer’s
TSPYL2 in G1 Checkpoint
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after collecting .20,000 cells with proper gating.
Immunocytochemistry and western blot
For immunocytochemistry, anti c-H2AX (Upstate Biotech) and
AlexaFlorH 594 anti-mouse IgG (Invitrogen) were used as primary
and secondary antibodies. The primary antibodies used in western
analysis included p53 (sc1311, Santa Cruz), acetyl-Lys379 p53
(#2570, Cell Signaling) and p21 (sc6246, Santa Cruz). Thirty mg
of protein samples were loaded in parallel gels, and anti-actin
(Sigma) was used as loading control. HRP-tagged secondary
antibodies were detected using ECL Plus system (Amersham).
RT-PCR and real-time quantitative RT-PCR (qPCR)
RNA was isolated by Trizol (Invitrogen). After digestion with
DNase I, 1 mg of RNA was reverse transcribed with SuperScript II
(Invitrogen). One-tenth of the resulting cDNA sample was used for
PCR. Semi-quantitative PCR was performed at 95uC for 5 min,
followed by 30 cycles of denaturation at 95uC for 45 seconds,
annealing at 58uC for 30 seconds, and elongation at 72uC for 45
seconds. The final extension was 7 minutes. The primers used
were listed as follows (59 to 39): F1: GGTTGCAGAGCCCAG-
CAG; R2: CACATTGGTTGATCAAGATTG; F2: GA-
GACCTCATCATCCAGCAT; R5: CCTCGTCTCATATAG-
TAG; F5; R6; Hprt-F: AACTGGAAAGAATGTCTTGATTG;
Hprt-R: TCAAATCCAACAAAGTCTGGC; Tspyl1-F: ATG-
GAAACAGCTGAGCCCTT; Tspyl1-R: AAAGGCAGGCGG-
ATTTCTGA; Tspyl2-QF: GGTCAAAGCATTCCTCAACC;
Tspyl2-QR: GGTCCTGTACCTGAAGATTG; Tspyl3-F: GCG-
AGGCTTAGAATATCCAG; Tspyl3-R: AGGTGCAAAGC-
TACCTTGCA; Tspyl4-F: AGCTTCTCCAAAGCTCGTAG;
Tspyl4-R: TGAGTGTTCCCAGGAGTCTT; Tspyl5-F: TTTG-
GGAGACTGGGGCATTG; Tspyl5-R: CAGAACACAGCAA-
CCCTAAC. qPCR was performed using the iQ SYBR Green
Supermix with ROX (Bio-Rad) on 7900HT System (Applied
Biosystems) according to manufacturers’ instruction. The expres-
sion of genes was calculated using the DDCT method after
normalization by Hprt (hypoxanthine guanine phosphoribosyl
transferase), which showed a similar level of expression in all
samples tested. Primers used were: Hprt-F, Hprt-R, Tspyl2-QF,
Tspyl2-QR, p21-F: CCTGGTGATGTCCGACCTGTT; p21-R:
GGGGAATCTTCAGGCCGCTC; Mdm2-F: TGAGACAGAA-
GAGAACACAG; Mdm2-R: CTTCCAATAGTCAGCTAAGG;
Noxa-F: TGCCAGCAGACTTGAAGGAC; Noxa-R: GGAAC-
CAAAAGCAAGCGAGC; 14-3-3s-F: TGTCTGTCCATC-
CTCGCAGT; 14-3-3s-R: CCTCCTCGTTGCTCTTCTGC;
Bax-F: CTCAAGGCCCTGTGCACTAA; Bax-R: ATGTGGG-
GGTCCCGAAGTAG.
Statistical analysis
Student t-test was used for pairwise comparison, and two-way
ANOVA followed by Bonferroni post-test were used for time-point
qPCR analysis. All graphs were presented as the average 6 SEM.
Results
Generation of Tspyl2 knockout mice
Tspyl2 deficient mice were generated using the targeting strategy
shown in Fig. 1A. Two targeted clones were obtained after
screening around one thousand ES colonies. The disruption of
Tspyl2 was confirmed by Southern blot analysis with both 59 and
39 external probes (Fig. 1B). Chimeric mice were generated from
blastocyst injection of targeted clones and crossed with wildtype
129Sv/Ev mice to generate the Tspyl2
m line of pure genetic
background. Genotypes of the pups were identified by PCR
(Fig. 1C). Mice of various genotypes occurred in the correct
Mendelian ratio. The Tspyl2 deleted line (Tspyl2
2) was generated
by crossing the Tspyl2
m line to outbred transgenic females
expressing Cre and genotyped by PCR (Fig. 1C).
To characterize the Tspyl2
m line, brain RNA samples were
collected for analysis. RT-PCR with primers amplifying exons 1 to
2, 2 to 5 and 5 to 6 under extended cycle number of 35 revealed
that the normal Tspyl2 transcript was eliminated in the Tspyl2
m/Y
mice. By contrast, the exon 2 to 5-deleted transcript was detected
after 30 PCR cycles in Tspyl2
2/Y mice (Fig. 1D). The data
indicated that none of the previously reported transcript variants
of mouse Tspyl2 was detectable in our two mouse lines [22]. To
assess the potential compensatory effect from other TSPYL
homologues, semi-quantitative RT-PCR was performed and no
obvious upregulation of other TSPY family members was detected
(Fig. 1E). In summary, the insertion of neo results in no stable
Tspyl2 transcript being detected. Tspyl2
m line was effectively a
Tspyl2knockoutline.Thisagreed with the finding that homozygous
and hemizygous mice in both Tspyl2
m and Tspyl2
2 lines were
phenotypically normal. We performed our analysis on the Tspyl2
m
mice since they were in pure 129/SvEv genetic background.
Normal proliferation of neuronal precursor cells in
Tspyl2
m animals
TSPY is functional in humans and rats but not in mice [23]. To
detect any species difference in the expression of its X-
chromosome homologue TSPYL2, we checked its expression in
mice. We previously reported that TSPYL2 is highly expressed in
the human heart, brain and lung as revealed by Northern blotting
[24]. High expression in the human heart was confirmed in two
additional RNA samples (data not shown). In mice, high
expression of Tspyl2 was detected in the brain but not the heart,
and lower expression was detected in gonads (Fig. 2A). Tspyl2
expression in cerebral cortex, hippocampus, gonads and thymus
was further compared by qPCR (Fig. 2B). Despite the expression
of Tspyl2 in gonads, Tspyl2
m/m and Tspyl2
m/Y mice were of normal
fertility. The morphology and size of Tspyl2 mutant brain were
also comparable to that of wildtype littermates (Fig. 2C). Since it
has been reported that TSPYL2 protein is detected in proliferating
neuron precursors in the adult brain, we further investigated the
consequence of gene knockout in the two brain areas where these
cells are found [25]. The numbers of BrdU labeled neuronal
precursors in dentate gyrus of the hippocampus and subependyma
surrounding the lateral ventricles were similar between wildtype
and mutant (Fig. 2D). The result shows that TSPYL2 is not
essential for proliferation of neuron precursors in adults.
Tspyl2 mutant cells proliferate normally in culture
We wondered whether TSPYL2 behaved as a tumor suppres-
sor, but we observed no spontaneous tumor development in our
mutant mice and their life span was normal. To reveal any subtle
role of TSPYL2 in cell proliferation, we used ES cells, primary
MEFs and thymocytes as sources of normal cells. The expression
of Tspyl2 in these cell types was measured by qPCR (Fig. 3A). The
level of Tspyl2 expression in thymocytes was similar to that of
thymus and set as 1 for comparison. ES cells and MEFs were
subjected to PI based cell cycle analysis. As Tspyl2 is subjected to
X-inactivation, heterozygous MEFs were excluded from analysis
as random inactivation of Tspyl2 had occurred [26]. Using early
passage cells, Tspyl2
m/Y cells had a normal cell cycle profile, with
no apoptotic or aneuploidy populations. The proportion of G1, S
and G2/M cell populations was similar between wildtype and
mutant from three independent experiments (Fig. 3B). In terms of
TSPYL2 in G1 Checkpoint
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wildtype and mutant MEFs were comparable and so did staining
with senescence-associated b-galactosidase at passage 6 (Fig. 3C
and data not shown). MEFs of both genotypes could be
spontaneously immortalized. Next, early passage MEFs were
synchronized with aphidicolin and nocodazole for transiently
arresting cells in G1 and G2 phase, respectively. Re-entry into cell
cycle through these checkpoints was measured by Flow cytometry
(Fig. 3D). Again, Tspyl2 mutant MEFs showed normal advance-
ment of cell cycle through both checkpoints after drug release.
Tspyl2 mutant MEFs are defective in cell cycle arrest
upon IR
Previous studies have shown that the transcription of TSPYL2 is
activated upon treatment with camptothecin, a potent inducer of
DNA strand breaks and inhibitor of topoisomerase I [12]. To further
dissect the importance of Tspyl2 in cell cycle control, we induced
DNA damage by IR. As ES cells are atypical in their response to
DNA damage, only MEFs were used in this study as sources of non-
transformed cells [27]. Early passage MEFs from wildtype and
mutant embryos were subjected to 10 Gy IR for the induction of
DNA double strand breaks. The proportion of S phase cells was
determined by Flow cytometry (Fig. 3E). With functional checkpoint
activation, normal MEFs undergo cell cycle arrest in response to
DNA damage for DNA repair. Initiation of G1 and G2 checkpoints
in mutant MEFs was normal, as indicated by a similar reduction in
the percentage of S phasecells and increase in G2/M cellsin wildtype
and mutant MEFs at 8 hours after IR. The proportion of S phase
cells in the wildtype remained low 24 hours after IR (35.9% 66% of
untreated, n=9). By contrast, a significantly larger proportion of
mutant MEFs had returned to S phase (77.51% 617.3% of
untreated, n=9, p,0.05). This suggests a defect in the maintenance
instead of initiation of the G1 checkpoint in the mutants.
Upstream of cell cycle arrest, histone H2AX is rapidly phosphor-
ylated on serine 139 (c-H2AX) which serves as a label of DNA
damage loci [28]. Mutant MEFs had a normal time course of DNA
Figure 1. Generation of Tspyl2 knockout mice. (A) Strategy for the target inactivation of Tspyl2. The targeting vector was constructed with neo
expression cassette inserted into intron 5 of Tspyl2 in reverse orientation. The deleted allele was generated through Cre-mediated excision. Exons 1
and 6 were numbered, and the positions of external probes for Southern Blot and primers for PCR were marked. (B) Southern blot analysis using the
59 and 39 probes on KpnI and XbaI digested ES cell DNA showed expected fragment sizes. +/Y: wildtype; m/Y targeted mutant. (C) PCR genotyping of
mice with PCR primers indicated. Typical results with DNA from wildtype male (+/Y), heterozygous Tspyl2
+/m female (+/m), Tspyl2
m/Y male (m/Y),
Tspyl2
+/2 female (+/2), Tspyl2
2/2 female (2/2). (D) Left: RT-PCR with 35 cycles showed that insertion of neo eliminated the normal Tspyl2 transcript
in Tspyl2
m/Y brain; Right: RT-PCR with 30 cycles showed the correct deletion of Tspyl2 exons in Tspyl2
2/Y. Primers were numbered according to exon
binding sites. (E) RT-PCR indicated that m/Y brain had no upregulation of other family members of Tspyl genes.
doi:10.1371/journal.pone.0021602.g001
TSPYL2 in G1 Checkpoint
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and mutant MEFs were both able to trigger the H2AX phosphor-
ylation, indicating normal recognition of DNA lesion. After 6 and
24 hours, the degree of lesion gradually decreased which indicated
DNA repair. The recovery rate of DNA damage in the mutant MEFs
was comparable with that of the wildtype controls (Fig. 4).
Impaired p21 transcription upon IR in mutant MEFs
In the presence of DNA damage, there is a rapid accumulation
of p53 and p21. In addition, acetylation of p53 promotes
recruitment of coactivator such as CBP to the p21 promoter
resulting in transcription activation [29]. While we observed no
consistent difference in the basal level of p53 and p21 between
wildtype and mutant MEFs, Lys379 of p53 was clearly acetylated
upon IR. There was also an increase in the protein level of p53
Figure 2. Tspyl2 mutant mice have normal proliferation of
neuronal precursor cells. (A) The expression pattern of Tspyl2 as
revealed by northern blot. Equal loading of RNA was visualized by
ethidium bromide staining. (B) qPCR analysis of Tspyl2 transcript in
cerebral cortex, hippocampus (Hippo), testis, ovary and thymus in adult
mice (n=3–5). The relative expression of each tissue is expressed as the
fold difference when compared with the thymus after normalization
with Hprt.( C) Gross morphology of the brain dissected from wildtype
(+/Y) and Tspyl2
m/Y (m/Y) adult mice after perfusion fixation. (D) BrdU
staining in dentate gyrus of hippocampus and lateral ventricle of 2
months old adult mice. Nuclei were stained by DAPI. Scale bar: 50 mm.
The number of BrdU-positive cells was counted and shown on the right.
Error bar: SEM.
doi:10.1371/journal.pone.0021602.g002
Figure 3. Tspyl2 is dispensable for cell proliferation, but
responsible for maintaining G1 checkpoint upon IR. (A)q P C R
analysis of Tspyl2 in MEFs, ES cells and thymocytes (Thy) (n=3–4). The
relative expression was expressed as the fold difference when compared
with thymocytes after normalization withHprt.( B) Rapidly growing EScells
and MEFs from wildtype (+/Y) and Tspyl2
m/Y mutants (m/Y) were subjected
to PI based cell cycle analysis. Cell populations from three independent
experiments were summarized. Error bar: SEM. (C) MEFs harvested from
wildtype (+/+ or +/Y, n=4) and Tspyl2
m mutants (m/Y or m/m, n=5) were
passaged under standard 3T3 protocol. Mutant and wildtype littermate
MEFs proliferated at a similar rate after prolonged passaging. (D) MEFs
were transiently treated with 5 mg/ml aphidicolin (unfilled) or 80 ng/ml
nocodazole (black filled) for 12 hours for synchronization in G1 or G2
phase.Progressionthroughcellcyclearrest afterthereleasewasmeasured
by PI based Flow analysis. Numbers indicated on the right represent the
hours released from synchronization treatment. (E) MEFs of passage 3
w e r ee x p o s e dt o1 0G yI Ra n df i x e da ti n d i c a t e dt i m ep o i n t sf o rF l o w
analysis. Left: A representative result showing the cell cycle analysis using
ModFit LTsoftware. The calculated G1 and G2/M phases were represented
by the two filled peaks, and the stripped portion in between
corresponding to S phase. Right: The percentage of cells at S and G2/M
fromfourindependentexperiments.Datawerepresentedasmean6SEM.
A significantly higher percentage of mutant MEFs had entered S phase
24 hours after IR (*: p,0.05, n=9 for each group).
doi:10.1371/journal.pone.0021602.g003
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of NAPs, TSPYL2 is likely to regulate transcription of various
checkpoint genes in DNA damage response. In support of this,
Tspyl2 mutant MEFs were defective in p21 induction after
exposure to 10 Gy IR (p,0.01). Thymocytes also showed
impaired p21 transcription activation 4 hours after IR (p,0.05,
Fig. 5B). Interestingly, the activation of other p53 target genes
Mdm2, 14-3-3s and the apoptotic genes Noxa and Bax was not
significantly different between wildtype and mutant MEFs and
thymocytes. The baseline level of expression of the above genes
was similar between wildtype and mutant in the qPCR assay.
Tspyl2 mutant thymocytes undergo apoptosis as control
cells upon IR
Both cell cycle arrest and apoptosis are protective responses
against DNA damage. In the case of thymocytes, more than 95% of
cells are resting at the G0/G1 phase before IR and therefore they
are not suitable for demonstrating cell cycle arrest. Upon IR, CD4/
CD8 double-positive thymocytes undergo apoptosis, and this
process is well-characterized to be dependent on the p53 activity,
both in vitro and in vivo [30]. Thymocytes isolated from irradiated
mice underwent IR-induced apoptosis, therefore the percentage of
CD4/CD8 double-positive cells dropped (Fig. 6A). In wildtype, the
percentage of CD4/CD8 double-positive cells dropped from 78.2%
62.2% to 18.6% 61.1% (n=2). Tspyl2
m mutant cells showed a
similar reduction from 75.3% 61.02% to 26.6% 62.5% after IR
(n=2). To substantiate the in vivo findings, mutant and wildtype
thymocytes were collected from non-irradiated mice and cultured
overnight. After acute exposure to 10 Gy IR, they showed the same
rateofcelldeathasmeasuredbyAVPI staining(Fig.6B).Therefore,
our data do not indicate a role of TSPYL2 in apoptosis.
Discussion
As a novel NAP identified in a number of screens, TSPYL2 is
shown to play a role in cell proliferation [6,11,12], TGF-b1s i g n a l i n g
pathway [15,31,32] and synaptic function [25,33,34]. Very little is
known about the physiological functions of NAPs and we address this
Figure 4. Normal DNA repair in Tspyl2 mutant MEFs. MEFs from
wildtype (+/Y) and Tspyl2
m/Y mutant (m/Y) were irradiated at 10 Gy and
collected at indicated time points for c-H2AX immunocytochemistry for
the detection of DNA damage foci. Scale bar: 200 mm. Cells (.200) with
various number of lesion foci were counted and the degree of damage
was summarized in the histogram on the bottom (n=2 for each
genotype). Data represented as mean value 6 SEM from two
independent experiments.
doi:10.1371/journal.pone.0021602.g004
Figure 5. Impaired transcription of p21 downstream of p53
stabilization upon IR in mutant cells. (A) Western Blot analysis of
lysates from wildtype (+/Y) and Tspyl2
m/Y mutant (m/Y) MEFs collected at
indicated time points post 10 Gy IR to acetyl-p53 at Lys379, total p53 and
p21. Actin served asa loading control. (B) qPCR analysis in MEFs(left panel)
and thymocytes (right panel) after IR at 10 Gy. Transcription levels of
indicatedcheckpointgenes werenormalizedbyHprt. The fold induction of
individual gene is expressed as mean value 6 SEM when compared to its
untreated control (n=5 per group). Data points showing asterisk indicate
statistical significance between wildtype and mutants as revealed by
Bonferroni post-test after 2-way ANOVA (*: p,0.05, **: p,0.01).
doi:10.1371/journal.pone.0021602.g005
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mutants amongst the TSPY family. While the loss of TSPYL2 has no
deleterious effects in mice we show there is a clear cell cycle defect
under the situation of DNA damage. Our results indicate that
TSPYL2 is required for cell cycle maintenance in stress condition.
Using MEFs derived from the mutant mice, we are able to reveal
therole ofTSPYL2incellcycleregulation.Tspyl2mutant MEFsare
defective in G1 cell cycle arrest upon IR. More specifically,
initiation of checkpoint response is normal as indicated by proper
triggering of the DNA damage response, accumulation of p53 and
p21 protein, and reduction in S phase cells within 8 hours after IR.
Failure in maintaining the checkpoint arrest in mutant cells is in
agreement with the molecular finding of impaired transcriptional
activation of p21. Upon stressful stimuli such as DNA lesions and
survival crisis, transcription of p21 is activated which serves as the
key initiator for cell cycle arrest. As p21 mutant MEFs are also
defective in blocking S phase entry after IR but have normal mitotic
spindle checkpoint induced by microtubule inhibitor, we attribute
the impaired G1 checkpoint in TSPYL2 mutant MEFs mainly to
impaired p21 induction. Other similarities between Tspyl2 and p21
knockout mice include the absence of gross developmental
abnormalities or spontaneous malignancies. Besides, apoptosis in
thymocytes is not affected [35]. Our data suggest that TSPYL2 is a
new player in transcription activation of p21 upon IR.
What causes the specific effect of TSPYL2 on the transcription
of p21 but not several other p53 target genes being tested? In a
previous report, reporter activity of the p21 promoter is
significantly activated by cotransfection of TSPYL2 expression
plasmid in HeLa cells. This is linked to the increased stability of
p53 protein [12]. Our data indicate that in MEFs, p53
stabilization upon IR is normal even without functional TSPYL2.
Concerning the role of TSPYL2, it has been proposed that binding
of NAPs to nucleosomal DNA facilitates the binding of
transcription factors to their DNA binding site [36]. NAPs also
strengthen the binding between transcription factor and p300/
CBP and this leads to transcription activation [2]. Another
possibility is NAPs perform their task of nucleosome displacement
after being recruited to the transcription complex [37]. In any
case, TSPYL2 is likely to recognize specific partner other than
p300/CBP to fine tune the transcription activity of specific p53
target genes.
G1 checkpoint is vital for delaying cell cycle progression upon
DNA damage, allowing more time for DNA repair and preventing
the replication of mutated template. Tspyl2 knockout MEFs
showed defective cell cycle arrest, but Tspyl2 mutant animals did
not suffer a higher tendency of tumorigenesis when compared with
wildtype littermates throughout eighteen months of observation.
Furthermore, mutant mice irradiated at 4 Gy did not develop
tumors after 6 months (data not shown). Due to the intricate
network of processes to control cell proliferation, there is potential
compensatory effect by other tumor suppressors. Very often the
cell cycle defects are revealed only by introduction of additional
mutation in another gene of the same family or working in the
same pathway, such as that observed in p21, atm double mutants
and Chk1, Chk2 double mutants [38,39]. In addition, the genetic
background of the mutant animals can affect the tumorigenic
observations [40]. We conclude that TSPYL2 is a new player in
controlling the cell cycle upon DNA damage.
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